Home Page: Radiotherapy and Oncology

• http://twitter.com/OncologyAdvance
• http://www.facebook.com/OncologyAdvance
• http://www.elsevier.com/journals/radiotherapy-and-oncology/0167-8140/open-access-options
• https://www.publishingcampus.elsevier.com
• http://ees.elsevier.com/ro/
• http://www.elsmediakits.com/journal_home/details/RADION
• http://www.estro.org
• http://www.caro-acro.ca
• http://www.redjournal.org
• http://www.journals.elsevierhealth.com/periodicals/home
• http://www.elsevierhealth.com
• http://www.oncologyadvance.com/
• http://www.estro.org/
• https://doi.org/10.1016/j.radonc.2019.04.012
• https://doi.org/10.1016/j.radonc.2019.03.010
• https://doi.org/10.1016/j.radonc.2019.04.010
• https://doi.org/10.1016/S0167-8140(19)30093-3
• https://doi.org/10.1016/S0167-8140(19)30092-1
• https://doi.org/10.1016/j.radonc.2019.07.010
• https://doi.org/10.1016/j.radonc.2019.06.035
• https://doi.org/10.1016/j.radonc.2019.06.030
• https://doi.org/10.1016/j.radonc.2015.07.041
• https://doi.org/10.1016/j.radonc.2014.11.030
• https://doi.org/10.1016/j.radonc.2015.01.016
• https://doi.org/10.1016/j.radonc.2013.10.010
• https://doi.org/10.1016/j.radonc.2016.07.017
• http://journalinsights.elsevier.com/journals/0167-8140
• http://www.sciencedirect.com/science/journal/01678140
• https://ees.elsevier.com/ro/OrcidValidation.asp
• http://www.ctro.science/
• http://phiro.science/
• http://tipsro.science/
• https://www.elsevier.com/
• https://www.elsevier.com
• https://www.elsevier.com/legal/privacy-policy
• https://www.elsevier.com/legal/elsevier-website-terms-and-conditions
• https://healthadvance.com/use-of-cookies
• https://www.elsevier.com/wps/find/intro.cws_home/ataglance
• https://www.healthadvance.com/accessibility
• https://www.relx.com/